Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study
Jon Rasmussen, Christian Selmer, Peter Busch Østergren, et al.
PLoS ONE (2016) Vol. 11, Iss. 8, pp. e0161208-e0161208
Open Access | Times Cited: 142

Showing 26-50 of 142 citing articles:

The Health Threat Posed by the Hidden Epidemic of Anabolic Steroid Use and Body Image Disorders Among Young Men
Anna L Goldman, Harrison G. Pope, Shalender Bhasin
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 4, pp. 1069-1074
Open Access | Times Cited: 52
Management of Anabolic Steroid-Induced Infertility: Novel Strategies for Fertility Maintenance and Recovery
Alexander J. Tatem, Jonathan Beilan, Jason R. Kovac, et al.
The World Journal of Men s Health (2019) Vol. 38, Iss. 2, pp. 141-141
Open Access | Times Cited: 51
Anabolic Androgenic Steroid Abuse: The Effects on Thrombosis Risk, Coagulation, and Fibrinolysis
Anna‐Marie Bloch Münster, Jørgen Gram, Johannes Jakobsen Sidelmann, et al.
Seminars in Thrombosis and Hemostasis (2018) Vol. 44, Iss. 08, pp. 734-746
Closed Access | Times Cited: 48
Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia?
Marc J. Kaufman, Gen Kanayama, James I. Hudson, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 100, pp. 180-207
Open Access | Times Cited: 48
Neuropsychiatric and Behavioral Involvement in AAS Abusers. A Literature Review
Giuseppe Bertozzi, Monica Salerno, Cristoforo Pomara, et al.
Medicina (2019) Vol. 55, Iss. 7, pp. 396-396
Open Access | Times Cited: 48
Long-term Anabolic–Androgenic Steroid Use Is Associated With Deviant Brain Aging
Astrid Bjørnebekk, Tobias Kaufmann, Lisa E. Hauger, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2021) Vol. 6, Iss. 5, pp. 579-589
Open Access | Times Cited: 38
Anabolic-Androgenic Steroid Use in Sports, Health, and Society
Shalender Bhasin, Disa L. Hatfield, Jay R. Hoffman, et al.
Medicine & Science in Sports & Exercise (2021) Vol. 53, Iss. 8, pp. 1778-1794
Open Access | Times Cited: 33
Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review
Massimiliano Esposito, Monica Salerno, Gianluca Calvano, et al.
Panminerva Medica (2022) Vol. 65, Iss. 1
Closed Access | Times Cited: 25
Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
Marie Lindvik Jørstad, Morgan Scarth, Svenn Torgersen, et al.
Brain and Behavior (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 15
The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men
Bonnie Grant, Joseph Kean, Naim Vali, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 15
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study
Hans Christian Bordado Henriksen, Ingrid Amalia Havnes, Marie Lindvik Jørstad, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 13
New perspectives in functional hypogonadotropic hypogonadism: beyond late onset hypogonadism
Matteo Spaziani, Francesco Carlomagno, C Tarantino, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids
Jon Rasmussen, Morten Schou, Christian Selmer, et al.
Clinical Endocrinology (2017) Vol. 87, Iss. 3, pp. 249-256
Closed Access | Times Cited: 41
Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?
Kyle Mulrooney, Katinka van de Ven, Jim McVeigh, et al.
Performance Enhancement & Health (2019) Vol. 6, Iss. 3-4, pp. 98-102
Open Access | Times Cited: 36
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Jim McVeigh, et al.
Substance Abuse Research and Treatment (2020) Vol. 14
Open Access | Times Cited: 36
Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study
Diederik L. Smit, Madelon M. Buijs, Olivier de Hon, et al.
Human Reproduction (2020) Vol. 36, Iss. 4, pp. 880-890
Open Access | Times Cited: 34
Premature Death in Bodybuilders: What Do We Know?
James M. Smoliga, Z. Taggart Wilber, Brooks Taylor Robinson
Sports Medicine (2023)
Open Access | Times Cited: 12
Getting big but not hard: A retrospective case-study of a male powerlifter's experience of steroid-induced erectile dysfunction
Justin Kotzé, Andrew Richardson, Georgios A. Antonopoulos
International Journal of Drug Policy (2023) Vol. 121, pp. 104195-104195
Open Access | Times Cited: 11
Elevated interleukin 8 and matrix metalloproteinase 9 levels are associated with myocardial pathology in users of anabolic-androgenic steroids
Ida Gregersen, Morgan Scarth, Rang Abdullah, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 12, pp. 1469-1476
Open Access | Times Cited: 4
Illegal and falsified medicines self-administrated in not approved post-cycle therapy after the cessation of anabolic-androgenic steroids – qualitative analysis
Agata Błażewicz, Magdalena Popławska, Beata Daniszewska, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Predicting Anabolic Androgenic Steroid Doping among Specialized Health Care Patients with Elastic Net Regression Reveals Potential Laboratory Variables for “Patient Biological Passport”
Paula Katriina Vauhkonen, Jari Haukka, Ilkka Vauhkonen, et al.
Sports Medicine - Open (2025) Vol. 11, Iss. 1
Open Access
Administration of anabolic steroid during adolescence induces long-term cardiac hypertrophy and increases susceptibility to ischemia/reperfusion injury in adult Wistar rats
Fernando A. C. Seara, Raiana Andrade Quintanilha Barbosa, Dahienne Ferreira de Oliveira, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2017) Vol. 171, pp. 34-42
Closed Access | Times Cited: 35
Looking Beyond the Provision of Injecting Equipment to People Who Use Anabolic Androgenic Steroids: Harm Reduction and Behavior Change Goals for UK Policy
Geoff Bates, Jim McVeigh, Conan Leavey
Contemporary Drug Problems (2021) Vol. 48, Iss. 2, pp. 135-150
Open Access | Times Cited: 26
Nonpharmacological Interventions for the Management of Testosterone and Sperm Parameters: A Scoping Review
Heitor O. Santos, Flavio Cadegiani, Scott C. Forbes
Clinical Therapeutics (2022) Vol. 44, Iss. 8, pp. 1129-1149
Closed Access | Times Cited: 18
Psychiatric morbidity among men using anabolic steroids
Josefine Windfeld‐Mathiasen, Thea Christoffersen, Niels August Willer Strand, et al.
Depression and Anxiety (2022) Vol. 39, Iss. 12, pp. 805-812
Open Access | Times Cited: 18

Scroll to top